Monday was quite the day for biotech companies developing the next generation of obesity drugs. One of them, Structure ...

Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...

Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

Picture the most successful companies in the world; they have one thing in common — an effective organizational structure. But what exactly does that entail and how can it make or break a business? If ...

A divisional organizational structure gives a larger business enterprise the ability to segregate large sections of the company's business into semi-autonomous groups. While generally better suited to ...

Each company tends to use the business structure that suits it best – there is no absolute right or wrong way to structure a business. Whether a particular structure is advantageous or disadvantageous ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

In his decades-long career in tech journalism, Dennis has written about nearly every type of hardware and software. He was a founding editor of Ziff Davis’ Computer Select in the 1990s, senior ...

There has been a plethora of experimental approaches that combine traditional chemical probing techniques with next-generation sequencing. These methods have allowed the first glimpse of the 'RNA ...

Even though there is a light at the end of the pandemic tunnel, chronic stress still rules the day. Those of us lucky enough to be employed are working harder than ever; an analysis of 3.1 million ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...